Block & replacement regimen is more cost effective than titration regimen in treating thyrotoxicosis in children, without more harm by unknown
POSTER PRESENTATION Open Access
Block & replacement regimen is more cost
effective than titration regimen in treating
thyrotoxicosis in children, without more harm
MK Anne Kwok*, PT Cheung
From 8th APPES Biennial Scientific Meeting
Darwin, Australia. 29 October – 1 November 2014
Aim
The first line treatment of thyrotoxicosis in our unit is
anti-thyroid medication for 2 years – longer if unstable
control. Since 2010, we changed the anti-thyroid treat-
ment protocol from block and replacement (B&R) to titra-
tion regimen (TIT), after the Cochrane review showed
that B&R was associated with similar remission rate but
more frequent adverse effects than TIT. We aimed at
comparing these 2 regimens in our pediatric patients.
Methods
Patients who received TIT from 2010 to 2014 for
relapse of thyrotoxicosis and previously had at least 1
full course of B&R were reviewed. Those who had less
than 2 years of TIT, either because they received surgery
or radioactive iodine within 2 years, or they have not yet
finished the course, were excluded from analysis.
The course of B&R versus TIT was compared within
each individual. For those who had previously multiple
courses of B&R, the latest course was used for analysis.
Occurrence of adverse drug side effects, length of the
anti-thyroid treatment course, number of clinic visits
and thyroid function tests during the course, and fre-
quency of abnormal free thyroxine levels were reviewed
and analyzed by paired t-test.
Results
27 patients, who received B&R previously, were put on
TIT for relapse of thyrotoxicosis after 2010. 17 patients
were excluded from the analysis as they were on TIT
for less than 2 years, 9 of them had surgery or radioac-
tive iodine within 2 years after starting TIT.
Among the 10 patients (4 males, 6 females, age 8-16
years) analysed, no significant drug side effect was
experienced during both treatment periods. While on
TIT, patients required longer duration of treatment
(average 23% longer, p=0.005) with more clinic visits
(average 50% increase, p=0.003) and thyroid function
tests (average 85% increase, p=0.002).
They needed more frequent clinic visits (average 22%
increase, p=0.04) and thyroid function tests (average
50% increase, p=0.007) per year. They had higher num-
ber of abnormal free thyroxine levels per year (average
28% more frequent, p=0.023). The percentage of abnor-
mal free thyroxine levels dropped insignificantly by 2.6%
(p=0.645).
The estimated drug cost for 2 year’s B&R was ~397
HKD (51.2 USD / 54.6 AUD), while 2 years’ TIT cost
~177 HKD (22.8 USD / 24.3 AUD).
Conclusion
Both B&R and TIT are safe without significant adverse
effect. B&R seems more cost effective with shorter treat-
ment duration and less frequent clinical and biochemical
monitoring, even drug cost is slightly higher.
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